Karaa, A., Bertini, E., Carelli, V., Cohen, B., Ennes, G. M., Falk, M. J., . . . Mancuso, M. (2024). Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: A post hoc analysis of the MMPOWER-3 trial. Orphanet journal of rare diseases, 19(1), 431-12. https://doi.org/10.1186/s13023-024-03421-5
Chicago Style (17th ed.) CitationKaraa, Amel, et al. "Genotype-specific Effects of Elamipretide in Patients with Primary Mitochondrial Myopathy: A Post Hoc Analysis of the MMPOWER-3 Trial." Orphanet Journal of Rare Diseases 19, no. 1 (2024): 431-12. https://doi.org/10.1186/s13023-024-03421-5.
MLA (9th ed.) CitationKaraa, Amel, et al. "Genotype-specific Effects of Elamipretide in Patients with Primary Mitochondrial Myopathy: A Post Hoc Analysis of the MMPOWER-3 Trial." Orphanet Journal of Rare Diseases, vol. 19, no. 1, 2024, pp. 431-12, https://doi.org/10.1186/s13023-024-03421-5.